Fifth Lane Capital’s Epizyme, Inc EPZM Stock Holding History

Fifth Lane Capital’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100,000	Closed	-$147K	–	342
2022 Q2	$147K	Buy	+100,000	New	+$73.5K	0.09%	156

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Fifth Lane Capital's EPZM Position: Q3 2022 in Review

Fifth Lane Capital sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 100,000 shares — an estimated $147K sold.

Fifth Lane Capital first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $147K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Fifth Lane Capital reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Fifth Lane Capital sold 100,000 Epizyme, Inc shares in Q3 2022, an estimated $147K.
Fifth Lane Capital first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Fifth Lane Capital's Epizyme, Inc position peaked at $147K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Fifth Lane Capital's 13F filing for Q3 2022, filed 14 Nov 2022.